Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

Two Pee Dee siblings are officially cured of sickle cell disease after more than a decade of living with the genetic blood ...

GREENVILLE, N.C. (WNCT) — WNCT’s Erin Jenkins sits down with a sickle cell disease survivor and a doctor to learn more about ...

AND017 is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor. The Food and Drug Administration has granted Orphan Drug designation to KIND Pharmaceutical’s AND017 for the ...

This suggests that SR-18292 can improve sickle cell disease pathology on its own. When combined with hydroxyurea, though, SR-18292 had an even larger effect on fetal hemoglobin production. "Our ...

Sickle cell thalassemia occurs when you inherit both a sickle cell gene mutation and a thalassemia gene mutation. Symptoms are similar to other types of sickle cell disease but can vary depending on ...

PHILADELPHIA (CBS) -- There's new hope for people with sickle cell disease, which affects mainly African Americans. It's gene therapy research at Children's Hospital of Philadelphia that's being ...

Please provide your email address to receive an email when new articles are posted on . Etavopivat reduced the annualized vaso-occlusive crises rate vs. placebo. The agent increased hemoglobin levels, ...

Sickle cell anemia is an inherited condition that impacts red blood cells. It can cause a variety of symptoms, which may include anemia, infections, and blockages in blood vessels. Sickle cell disease ...

Newborn screening will now be mandatory at birth, and children diagnosed with the disease will be followed up to manage ...